Skip to main content
. Author manuscript; available in PMC: 2023 Mar 23.
Published in final edited form as: Health Aff (Millwood). 2022 Apr;41(4):497–506. doi: 10.1377/hlthaff.2021.01483

Exhibit 4.

Adjusted relative rate of most or moderately effective contraception provision by Title X funding status, 2016–2018

Relative increase for Title X clinics compared to non-Title X clinics 95% confidence interval (lower bound, upper bound)
Most effective
Overall 1.52 (1.23, 1.88)
Adolescents (15–19 years) 1.58 (1.24, 2.02)
Young Adults (20–24 years) 1.26 (0.98, 1.61)
Adults (25–49 years) 1.46 (1.17, 1.83)
Moderately effective
Overall 1.49 (1.29, 1.73)
Adolescents (15–19 years) 1.35 (1.11, 1.62)
Young Adults (20–24 years) 1.34 (1.13, 1.58)
Adults (25–49 years) 1.61 (1.33, 1.94)

SOURCE: Study-generated data.

NOTE: Most effective contraceptives: intrauterine devices or contraceptive implants. Moderately effective contraceptives: oral pill, patch, contraceptive injection, vaginal ring.

Adjusted means estimate (relative rate) of prevalence of contraception provision by Title X clinics vs non-Title X clinics, averaged across the entire study period, from a total of 4,608 clinic-quarters, 2016–2018. Estimates obtained from Poisson regression model with log link and autoregressive correlation structure with robust variance estimator; relative rate estimates from LSM estimate contrast statement of quarter*Title X interaction.